Available until July 31, 2024 - Online CME Course

Breast cancer risk assessment entails understanding clinical and genomic risk factors. Available risk calculation models provide population level risk with limitations in implementation in clinical practice. We need to advance the paradigm and transition to precision prevention and personalized risk stratification. With accurate risk assessment clinicians can optimize clinical benefits including surveillance imaging and risk reducing medication options. New research on the use of single nucleotide polymorphisms and polygenic risk score could be useful for stratifying and predicting individualized breast cancer risk and enhance shard decision making opportunities in management of women at increased risk for breast cancer

Available until September 1, 2024 - Podcast Online CME Education

Serena Mitaly, PharmD shares strategies for pharmacogenomic research translation to reduce health disparities.

Available until February 1, 2026

Among adolescents, complaints regarding fatigue are relatively common and it’s been assumed to be associated with the hormonal changes of puberty, the various social conflicts common in adolescence and a variety of educational expectations. At times, fatigue becomes chronic and may be accompanied by other physical symptoms including mood disorders, headaches, musculoskeletal pains, and various GI symptoms. When chronic fatigue in adolescence has been investigated, no single causal factor has been found and its likely to be multi-factorial. The topic for this podcast is “Chronic Fatigue in Adolescents” and we’ll discuss this with our guest Philip R. Fischer, M.D., a pediatrician from the Department of Pediatrics at the Mayo Clinic.

Available until July 31, 2024 - Online CME Course

Left main coronary artery (LMCA) disease can have life-threatening consequences for adults of all ages. Management decisions can play a significant role in providing the best long-term benefit for patients, while mitigating the risks related to revascularization. In this one-hour webinar from Mayo Clinic Healthcare in London, our experts discuss a pragmatic approach for shared decision-making for patients with LMCA disease.

Available until February 1, 2026

Hearing loss is a commonly seen symptom in a primary care office practice, as is tinnitus and vertigo. Fortunately, they’re almost always due to a benign cause. However, these symptoms may represent something more ominous, an acoustic neuroma, also known as a vestibular schwannoma. It’s important to consider this diagnosis when we see them in our patients, as there is the potential for serious consequences to develop if this remains untreated. What type of hearing loss is associated with a vestibular schwannoma? What are the other associated symptoms? How do we go about evaluating these patients and how are they best treated? I’ll be asking these questions of our guests Michael J. Link, M.D., a neurosurgeon from the Department of Neurologic Surgery and Mathew L. Carlson, M.D., a head and neck surgeon from the Department of Otolaryngology, both at the Mayo Clinic in Rochester, Minnesota. Our topic for this podcast is vestibular schwannomas.

Available until February 1, 2026

Nearly 1 million individuals in the U.S. have multiple sclerosis. Most acquire the disease between the ages of 20 and 50. It’s often difficult to establish a diagnosis as the symptoms can be vague and often vary significantly from one individual to another. The disease can be very frightening, often debilitating, and progressive; up until recently, we’ve had very little to offer patients in the way of treatment. However, in the past few years there have been numerous advances in treatment options which have given hope to the many patients with MS. We’ll be discussing multiple sclerosis in this podcast. Our guest is Eoin Flanagan, M.B., B.Ch., a neurologist from the Department of Neurology at the Mayo Clinic.